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ABSTRACT 
Most of the controlled release systems developed for drug delivery applications depend 
on membrane technology. The dense structure of the membrane in conventional 
controlled release systems prolongs the release of drug. To eliminate this disadvantage 
while maintaining the benefits of dense membrane systems, an asymmetric type of 
coating was applied on tablets. Coatings were prepared from cellulose acetate, acetone, 
water solution by phase inversion technique. To determine the release rate of drug, 
dissolution studies on tablets were performed according to United States of 
Pharmacopeia (USP). In these studies, the effects of composition of the 
polymer/solvent/nonsolvent, coating time, number of coating layers, evaporation 
conditions and the nonsolvent type on the release rate of the drug and the structure of 
membrane were investigated. Experiments were designed using commercial software 
package Design-Expert and a quadratic model equation was obtained to predict the 
effect of composition of cellulose acetate, acetone and water on the release rate of drug. 
The advantage of asymmetric type coating over the conventional dense type coating 
was further demonstrated by measuring the permeabilities of both type of coatings. In 
addition, the structures of membranes were analyzed using scanning electron 
microscope (SEM) micrographs. 
  
ÖZ 
İlacõn vücutta kontrollü salõmõ için geliştirilen sistemlerin birçoğu membran 
teknolojisine dayalõdõr.Geleneksel kontrollü salõm sistemlerinde kullanõlan yoğun 
yapõdaki membranlar ilaç salõmõnõ uzatmaktadõr. Bu dezavantajõ ortadan kaldõrmak için, 
yoğun yapõdaki membran sistemlerinin yararlarõ sabit tutularak tabletlere asimetrik 
yapõdaki kaplamalar uygulanmõştõr. Kaplamalar faz ayrõmõ yöntemi ile selüloz asetat, 
aseton ve su çözeltisi kullanõlarak hazõrlanmõştõr. İlacõn salõm hõzõnõ belirlemek için, 
tabletlerin çözünme çalõşmalarõ United States Pharmacopeia (USP) standartlarõna göre 
yapõlmõştõr. Bu çalõşmalarda, polimer/çözücü/çözücü olmayan kompozisyonlarõnõn 
etkileri, kaplama zamanõ, kaplama sayõsõ, buharlaşma koşullarõ ve çözücü olmayan 
malzemenin ilaç salõm oranõna ve membran yapõsõna etkisi incelenmiştir. Deneyler ticari 
bilgisayar yazõlõm programõ Design-Expert kullanõlarak tasarlanmõş ve selüloz asetat, 
aseton ve su kompozisyonunun ilaç salõmõna etkisini belirlemek için kuadratik model 
denklemi elde edilmiştir. Asimetrik yapõdaki kaplamalarõn geleneksel yoğun yapõdaki 
membrana göre avantajõ, her iki tipteki kaplamalarõn geçirgenlikleri ölçülerek de 
kanõtlanmõştõr. Buna ek olarak, taramalõ elektron mikroskobu fotoğraflarõ incelenerek 
membran yapõlarõ analiz edilmiştir. 
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CHAPTER 1 
INTRODUCTION 
The use of different systems as a means of delivering a wide variety of active 
ingredients such as drugs, pesticides, fragrances at a specified rate and a desired 
location for a specified period of time is called “Controlled-Release” Technology. 
Studies on “controlled-release systems” began to be developed for agricultural products 
in the 1950’s, and such approaches were extended to medicine in the 1960’s.  
The significant growth of controlled-release technology for drug delivery applications 
was due to general-dose delivery problems. During conventional treatments, drug 
concentration may exceed maximum toxic level or may fall below the ineffective level 
requiring to take several doses, so increasing the likelihood of unwanted side effects. To 
prevent these problems, different controlled-release systems were developed to deliver 
the optimum doses at the right time and to the right place. 
Among the many controlled-release systems developed and commercialized since 
1950’s, the most widely used ones depend on membrane technology. In these systems 
the release of drug surrounded by a swollen or non-swollen polymeric membrane is 
controlled by diffusion of drug through the membrane. The structure of the membrane 
in conventional controlled-release systems is usually dense and symmetric, thus influx 
of water into the membrane is slow, prolonging the release of drug. This is a principal 
problem with dense membrane coatings. To increase the permeability of the membrane, 
thus to achieve useful drug release rates, various attempts have been reported, including 
plasticizers and water-soluble additives incorporated in the coating and multilayer 
composite coatings. To increase coating permeability further, a new type of membrane 
coating has been developed, that offers significant advantages over the membrane 
coatings used in conventional tablets. These membranes consist of a thin, dense outer 
skin layer supported on a highly permeable, thicker and porous layer that provides 
mechanical strength and durability. The drug release rates from tablets or capsules 
coated with this new type of membranes can be adjusted by controlling the membrane 
structure without changing coating material or varying the coating thickness. 
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In this study, the last novel approach was adopted and asymmetric membrane coated 
drug tablets were prepared by phase inversion process. Drug tablet is coated by first 
dipping into the membrane forming solution and then allowing it to dry. The coating 
solution consists of polymer, solvent and nonsolvent, which does not dissolve the 
polymer completely. During evaporation, initially homogeneous polymer solution 
becomes unstable and is separated into polymer lean and polymer rich phases. As a 
result, asymmetric type of coating is obtained. 
Throughout this study, cellulose acetate was chosen as a membrane-forming polymer 
since it is a water-insoluble, biodegradable and natural polymer, acetone was used as a 
solvent and theophylline was chosen as a model drug. 
The dissolution studies on coated tablets were performed according to United States 
Pharmacopoeia (USP) standards. In these studies different nonsolvents were used in 
solution to investigate their effect on membrane structure. Additionally, the effects of 
the initial composition of the solution, number of coating layer, coating (dipping) time 
and the evaporation condition on the structure of the membrane and the release rate of 
theophylline were examined. In order to draw meaningful and objective conclusions 
from the data, statistical design of experiments was performed for cellulose acetate, 
acetone, water system using commercial software package called Design-Expert. In the 
design of the experiments, the release rate of theophylline was chosen as the response, 
while composition of cellulose acetate, acetone and water were considered as variables 
affecting the response. In order to further demonstrate the advantages of the asymmetric 
type of coatings, the permeability of different membranes prepared by varying the 
compositions of the polymer/solvent/nonsolvent were also measured. In addition, the 
morphology of the membranes was observed using scanning electron microscope.  
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CHAPTER 2 
CONTROLLED-RELEASE SYSTEMS 
Controlled-release technologies are designed to deliver active agents at a specified rate, 
at a desired body site for a specified period of time. The goal of the rate-controlled 
technology is to produce a convenient, generally self-administered dosage form that 
yields a constant infusion of the drug. 
 
Figure 2.1. Concentration profiles for (a) conventional (b) controlled-release 
formulations. 
Controlled-release formulations offer 
• greater efficacy because optimal concentrations of active ingredient can be 
maintained in the environment of use  
• improved safety from reliable release kinetics and control over the amount of 
active ingredient available at any one time 
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• greater convenience because fewer applications or treatments are needed  
Controlled-release dosage forms provide sustained drug release and require less 
frequent drug loading than conventional forms. This is an important advantage for 
patient compliance during medication. 
Patients required to take 1 or 2 dosage unit a day are thought to be less likely to forget a 
dose than if they were required to take their medication 3 or 4 times a day. Further, 
controlled-release dosage forms allow whole day coverage and help to reduce the need 
for the patient to be awakened for an early morning dosing. Also, depending upon the 
medication and the dosage form, the daily cost to the patient may be less frequent 
dosage administration (Ansel and Popovivch, 1990). 
2.1. Advantages and Disadvantages of Controlled-Release Systems 
In controlled-release systems, plasma drug levels are maintained in a therapeutically 
desirable range. Drug blood level fluctuations are reduced that means by controlling the 
rate of drug release, “peaks and valleys” of drug-blood or –serum levels are eliminated. 
Rate-controlled products deliver more than a single dose of medication and thus are 
taken less often than conventional forms (Ansel and Popovivch, 1990) so dosing 
frequency is reduced. Harmful side effects are minimized. Because there are seldom 
drug blood level peaks above the drug’s therapeutic range, and into the toxic range, 
adverse side effects are less frequently encountered (Ansel and Popovivch, 1990). 
Patient convenience and compliance are improved. With less frequency of dose 
administration, the patient is less suitable to neglect taking a dose. There is also greater 
patient convenience with daytime and nighttime medication, and control of chronic 
illness (Ansel and Popovivch, 1990). Although the initial cost of rate-controlled drug 
delivery systems is usually higher than conventional dosage forms, the average cost of 
treatment over an extended time period may be lower with less frequency of dosing, 
enhanced therapeutic benefit, and reduced side-effects, and, reduced time period of 
health care personnel to dispense, administer and monitor patients (Ansel and 
Popovivch, 1990). 
Besides the advantages of controlled-release systems, there are some disadvantages in 
any specific clinical application. Toxicity or lack of biocompatibility of the polymer 
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material used is one of these problems. Biocompatibility is very important because it 
relates to the ability of the polymer to remain biologically inert during implantation. 
Another problem is production of harmful byproducts from the polymer if it is 
biodegradable but this problem exists in bioerodible systems. Expense of the fabrication 
procedure of polymer-drug formulation is another disadvantage of controlled-release 
systems. 
2.2. Classification of Controlled-Release Systems 
2.2.1. Diffusion-Controlled Release Systems 
2.2.1.1. Reservoir Systems 
In these systems, a core of drug is surrounded by a rate-controlling membrane, and 
active agent is released by diffusion through the membrane. Several types of reservoir 
systems are coated tablets, beads, and particles, membrane-based pouches  
(e.g. transdermal drug delivery systems), and microcapsules. 
A critical problem, from a pharmaceutical standpoint, is the ability to achieve zero-
order release rates; the principal advantage of reservoir systems is the ease with which 
they can be designed to achieve these kinetics (Langer and Peppas, 1981). In other 
words, reservoir systems typically provide a constant rate of release over a substantial 
portion of the duration of release. The desired rate of release can usually be achieved by 
properly selecting the rate-controlling membrane. If the diffusivity and the 
concentration gradient across the membrane remain constant, then the release rate will 
be constant (zero-order release). To maintain a constant concentration gradient, the 
activity of the active ingredient within the reservoir must remain constant and transport 
to and from the membrane surfaces must be rapid with respect to transport through the 
membrane (Smith and Herbig, 1992). In reservoir systems release rate depends on the 
membrane thickness, permeability and area. 
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Figure 2.2. Idealized diffusion-controlled reservoir release system. 
There are four types of reservoir devices: 
In nonporous polymeric membranes, the active ingredient exists in a highly saturated 
state (with excess solid phase present) within the reservoir and is able to diffuse through 
the membrane in response to a gradient in thermodynamic activity. As long as the 
solution within the reservoir is saturated and sink conditions are maintained at the 
releasing film interface, the concentration gradient across the membrane remains 
constant and the release of the drug follows zero-order kinetics (Cahn and Haasen, 
1992). 
The active ingredient passes through liquid-filled pores rather than through the polymer 
itself in microporous membranes. To prolong release, the active agent should have a 
low but finite solubility in the liquid phase, which fills the pores (Cahn and Haasen, 
1992).  
Microencapsulation of active agents by polymeric materials is a process yielding small 
solid particles or liquid droplets enclosed by an intact, thin shell of polymeric material 
(Cahn and Haasen, 1992). The release of agent may be result of erosion of the 
polymeric shell or of diffusion through the shell. Commonly, release is by a 
combination of erosion and diffusion. 
Osmotic pressure was first employed as an energy source to deliver active ingredients in 
the 1950s (Liu et al., 2000b). During the past some two decades, there has been a 
growing interest in developing osmotic pump dosage forms for controlled delivery of 
drugs. The elementary osmotic pump (EOP) was introduced by Theeuwes and the 
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coworkers in 1970s (Liu et al., 2000a). In osmotic pump systems, the core contains 
water-soluble drug and it is enclosed with water-permeable but drug-impermeable 
polymeric membrane that has a small opening. The release rate may be controlled by 
changing the surface area, the thickness or the nature of the membrane and by changing 
the diameter of the drug release orifice. 
 
Figure 2.3. Schematic diagram of the osmotic tablet system surrounded by membrane    
drilled with two orifices. 
Osmotic drug delivery systems are based on osmosis, the diffusion of water across a 
semipermeable membrane from a solution with a low osmotic pressure to a solution 
with a high osmotic pressure. Water is imbibed into the core through the coating; a 
hydrostatic pressure generated within the core forces or “pumps” a drug containing 
solution out of the core from delivery ports. 
Osmotic systems characteristically provide a constant rate of release as long as the 
osmotic gradient across the rate-controlling membrane is constant and as long as the 
concentration of active ingredient that remains in the reservoir is constant (Smith and 
Herbig, 1992). 
The osmotic pump tablet system for oral administration has many advantages such as 
(Liu et al., 2000a): 
• Constant delivery rate and thereby reduced risk of adverse reactions 
• Extended action period and hence improved patient compliance 
• In vivo predictability of release rate on the basis of in vitro data 
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2.2.1.2. Matrix Systems 
Matrix systems consist of active ingredients dissolved and/or dispersed throughout a 
polymer. If the active agent is dissolved within a nonporous polymer matrix, transport 
of the active agent is presumed to occur by a process involving diffusion along and 
between the polymer segments. If the active agent is dispersed within a polymer matrix, 
solute transport may occur by either a partition mechanism wherein the process involves 
diffusion along and between the polymer segments or a pore mechanism wherein 
transport occurs through microchannels that exist or are created by previous 
solubilization of active agent within the polymer network (Cahn and Haasen, 1992). 
 
 
Figure 2.4. Idealized diffusion-controlled matrix tablets. 
Release characteristics of matrix systems are not generally zero-order. Release rates 
decrease with time since the path length for diffusion increases with time as the active 
ingredient near the surface is released first and that in the interior must diffuse farther to 
be released (Smith and Herbig, 1992). 
2.2.2. Chemically-Controlled Systems 
2.2.2.1. Bioerodible Systems 
In these systems, an active agent is dispersed into the biodegradable polymer. The 
release rate of the dispersed active agent may be influenced by the rate of diffusion 
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and/or degradation. The process of biodegradation involves systems, which must first 
undergo hydrolysis of covalent bonds in order to allow for concomitant solubilization of 
small pieces of the matrix (Cahn and Haasen, 1992). During the release process, the 
drug delivery in the erodible hydrophilic matrix is controlled by two mechanisms. 
While poorly soluble drugs are released solely by erosion of the gel, water-soluble 
drugs are released both by diffusion out of gelatinous layer and by the erosion of the gel 
(Karasulu et al., 2000).  
Figure 2.5. Idealized drug release from bioerodible systems (a) surface erodible (b) bulk 
erodible. 
Bioerodible systems have a significant advantage over non-erodible systems in many 
applications because biodegradable polymers are eventually absorbed by the body, 
obviating the need for surgical removal. However, this advantage must be weighed 
against the potential disadvantage that the absorption products may be toxic, 
immunogenic, or carcinogenic (Langer and Peppas, 1981).  
2.2.2.2. Pendant Chain Systems 
In pendant chain systems, drug is bound to a polymer backbone chain chemically and is 
released by hydrolytic or enzymatic cleavage. The drug itself can be attached directly to 
the polymer or it can be attached via a spacer group. The spacer group may be used to 
affect the rate of release and hydrophilicity of the system (Langer and Peppas, 1981).
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Figure 2.6. Idealized drug release from pendant chain systems. 
2.2.3. Swelling – Controlled Systems 
The drug is dissolved or dispersed in a polymer solution and after the evaporation of the 
solvent, glassy polymer matrix is obtained. Upon contact with biological fluids, water 
penetrates into the tablet and dissolves the drug, which then diffuses out of the tablet. In 
contrast to purely diffusion-controlled drug delivery systems, additionally swelling and 
polymer dissolution have to be taken into account. Above a certain, critical water 
concentration, the polymer undergoes the transition from glassy to the rubbery state, 
leading to dramatic changes in volume, concentration and diffusion coefficients of the 
involved species (Siepmann and Peppas, 2000). 
 
Figure 2.7. Idealized swelling-controlled release system. 
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In swellable matrix tablet, three fronts could be expected: 
the swelling front, the boundary between the still glassy polymer and its rubbery 
state 
the diffusion front, the boundary in the gel layer between the solid, as yet the 
undissolved, drug and the dissolved drug 
the erosion front, the boundary between the matrix and the dissolution medium 
The measurement of front positions provides the possibility to determine three 
important parameters related to the behavior of the matrix, i.e. the rate of matrix 
erosion, associated with the movements of the swelling front, diffusion front and 
erosion front, respectively (Colombo et al., 1996). 
2.2.4. Magnetically - Controlled Systems 
Drug and small magnetic beads are uniformly dispersed within a polymer matrix. Upon 
exposure to aqueous media, drug is released in a fashion typical of diffusion-controlled 
matrix systems. However, upon exposure to an oscillating external magnetic field, drug 
is released at a much higher rate (Langer and Peppas, 1981). 
2.3. Polymers For Drug Release Formulations 
Various types of polymers have been used in the design of drug delivery systems. The 
choice of the polymer and proper design of the polymer-drug formulation is of critical 
concern in all controlled-release formulations. The selection of polymer can 
• affect diffusion and partition coefficients in diffusion-controlled systems 
• affect the rate of erosion or hydrolysis in chemically-controlled systems 
• affect the permeation rates of solvents in swelling-controlled systems 
• presumably affect the mechanical forces in magnetically-controlled systems 
(Langer and Peppas, 1981) 
The goal in developing a controlled-release system is to make it as close as possible to 
the ideal system. An ideal system should have the following characteristics. It would: 
• generally display zero-order kinetics 
• be inert and compatible with the environment 
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The toxicity, biocompatibility and immunogenicity of the polymeric device is critical 
because the device interfaces directly with the biological environment in which it is 
injected, implanted or inserted (Cahn and Haasen,1992). Therefore it should be 
biocompatible, non-toxic, non-mutogenic, non-carcinogenic, non-teratogenic and non-
immunogenic. Additionally, it should 
• be comfortable to the user 
• be easily administered 
• possess a high drug/polymer ratio 
• be easy and inexpensive to fabricate 
• be safe and free from leaks 
• have good mechanical strength 
• be easily sterilizable 
In the case of matrix or membrane systems, one must demonstrate that the properties of 
the polymer are not affected by prolonged exposure to the biological environment. 
Furthermore, with bioresorbable systems, all polymeric degradation products as well as 
their metabolites must be non-toxic, non-carcinogenic, and excreted without excessive 
permanent accumulation in the tissues (Cahn and Haasen, 1992).  
2.4. Release Kinetics 
The release of active ingredients from controlled-release systems can follow a wide 
variety of patterns. However, the release kinetics from most systems that depend on 
membrane diffusion can be grouped into three release profiles: 
• zero-order kinetics 
• t –1/2 kinetics 
• first-order kinetics 
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Figure 2.8. Comparison of release kinetics from conventional (first-order) and 
controlled-release formulations. 
In zero-order kinetics, the release rate remains constant until essentially all of the active 
ingredient has been delivered. The term zero order that is a time-independent rate, 
derives from the release kinetics being independent of the quantity of drug remaining, 
i.e., drug concentration term raised zero power. 
The release rate decreases proportionately to the square root of time in controlled-
release systems with t –1/2 kinetics (Smith and Herbig, 1992). 
For systems exhibiting first-order kinetics, the release rate is proportional to the quantity 
of drug remaining in the system, i.e., proportional to the quantity to the first power, 
doubling the dose doubles the transfer rate. 
The goal of a controlled release formulation is to improve the therapeutic value of the 
active drug component by reducing the ratio of the maximum and minimum plasma 
drug combination (Cmax/Cmin) while maintaining drug plasma levels within the 
therapeutic window. The controlled release form seeks to give a drug with sufficient 
frequency and dose so that the ratio Cmax/Cmin in plasma at steady state is less than the 
therapeutic index, and to maintain drug levels at constant effective concentrations. In 
principle, in order to keep a constant plasma drug level, the drug formulation should be 
  14 
designed to provide an input rate into the body that is or approaches zero order, 
although in vivo profiles rarely match zero order kinetics based on in vitro models. 
For both t –1/2 and first-order systems most of the active ingredient is released during the 
first third of the total duration of release. Depending on the specifications for particular 
controlled-release formulations, either zero-order or t –1/2 systems are typically preferred 
(Smith and Herbig, 1992). 
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CHAPTER 3 
PREVIOUS STUDIES ON CONTROLLED-RELEASE SYSTEMS 
3.1. Matrix Systems 
The first study on matrix systems was conducted by Picker and Bikane (1998). They 
investigated the dependency of drug release from tablet formation and the factors 
influencing the microstructure of the tablet, such as densification, different particle size 
fractions, the dwell time during tableting and different drug concentrations. Their results 
show that it is only possible to produce a matrix tablet with cellulose acetate for 
controlled release applications by using longer dwell times. Without longer dwell times 
and the hydrostatic stress evolving during this process the bonding in the cellulose 
acetate matrix is dominated by hydrogen bonding which can be dissolved by the release 
medium. 
Qiu et al. (1998) studied on the devices that consist of a hydrophobic middle layer and 
press-coated hydrophilic and/or hydrophobic barrier layer(s). The aim of producing 
such tablets was to overcome the inherent disadvantage of non-linear release associated 
with diffusion-controlled matrix devices by providing additional releasing surface with 
time to compensate for the decreasing release rate. In vivo release experiments were 
done using nine beagle dogs. At the end of the study they have concluded that zero-
order or near zero-order release can be obtained using the proposed system designs 
which overcome the major disadvantage of nonlinear release associated with matrix 
devices.  
Gren and Nyström (1999) prepared a multipleunit extended-release matrix by 
incorporating a hydrophilic drug (paracetamol) and lipophilic release modifiers (cetyl 
alcohol and paraffin) into porous cellulose matrices and they controlled the release rate 
by varying the ratio of cetyl alcohol to paraffin. The porosity of the matrix was found to 
increase during release due to formation of cracks and voids as cellulose swelled. Their 
results indicated that the rate of drug release is mainly controlled by diffusion through 
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the matrix but is also affected by the distribution of drug in the matrix and increase in 
porosity of the matrix. 
Streubel er al. (2000) used two different polymers as matrix formers, the water insoluble 
and almost unswellable ethylcellulose (EC), and the water-soluble and highly swellable 
hydroxypropyl methylcellulose (HPMC). They proposed two different approaches to 
solve problem of pH-dependent release of weakly basic drugs. The first one is based on 
the addition of hydroxypropyl methylcellulose acetate succinate (HPMCAS, an enteric 
polymer), the second one is based on the addition of organic acids to the drug-polymer 
system. As a result they have found that the addition of HPMCAS to ethycellulose-or 
HPMC- based matrix tablets failed to achieve pH-independent drug release, whereas the 
addition of organic acids to both matrix formers maintained low pH values within the 
tablets during drug release in phosphate buffer (pH 6.8 or 7.4) leading to pH-
independent drug release.  
3.2. Bioerodible Systems 
Karasulu et al. (2000) investigated how various geometrical shapes such as triangle, 
cylinder, and half-sphere affect the release rate of theophylline from erodible hydrogel 
matrix tablets. They found that the release rate is highest from triangular tablets and 
lowest from cylindrical tablets. 
3.3. Swelling Systems 
Bettini et al. (1995) studied the swelling behavior and transport in swellable, ionic 
copolymers of 2-hydroxyethyl methacrylate and methacrylic acids for a wide range of 
copolymer compositions. The swelling behavior was determined by investigating the 
time -dependent change of the swelling and erosion front positions and associated gel 
layer as a function of the percentage of the ionic component (MAA). In addition, release 
of theophylline and metoclopramide-HCl were studied as a function of time. As a result 
they have found that the relatively rapid penetration of water established a water 
gradient within the hydrogel that led to a slower polymer swelling.  
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In another study, Bell and Peppas (1995) were measured the swelling force of 
interpolymer complexes as a function of time in various pH buffered solutions, and 
analyzed the results to determine the contributions of chain relaxation and diffusion on 
the swelling force. Their results indicated that chain relaxation is an important 
mechanism in the development of the swelling force. 
To establish the relationship between front position and drug release kinetics Colombo 
et al (1996) studied on the movement of the penetrant and polymer fronts and the drug 
dissolution in highly loaded swellable matrix tablets. They confirmed that in swellable 
matrix tablets drug release rate is inversely proportional to the dynamics of gel layer 
thickness, which remains constant when the polymer is sufficiently soluble.  
3.4. Membrane Systems 
Liu et al. (2000a) studied with the sandwiched osmotic tablet system (SOTS), which is 
composed of a sandwiched osmotic tablet core surrounded by a cellulose acetate 
membrane with two orifices on both side of the surfaces for delivering nifedipine. They 
investigated the influences of tablet formulation variables, orifice size and membrane 
variables on nifedipine release from SOTS. As a result they found that two orifices with 
diameter ranging from 0.5 to 1.41 mm are suitable for the SOTS. Liu et al. (2000b) also 
studied with the monolithic osmotic tablet system, that consists of a monolithic tablet 
core coated with cellulose acetate membrane drilled with two orifices. The influences of 
tablet formulation variables including molecular weight and amount of polyethylene 
oxide, amount of potassium chloride, and amount of rice starch as well as nifedipine 
loading were investigated on drug release rate. They have found that both KCl and PEO 
had comparable positive effects, while the loading of nifedipine had a negative 
influence on drug release and they observed that the optimal orifice size was in the 
range of 0.25-1.41 mm and their results indicated that the hydrophilic plasticizer, PEG, 
improved drug release, whereas the hydrophobic plasticizer, triacetin, depressed drug 
release when they were incorporated in the CA membrane. Finally they have shown that 
monolithic osmotic tablet system was found to be able to deliver nifedipine at a rate of 
approximately zero-order up to 24 h, independent of both environmental media and 
agitation rate.  
  18 
Graham et al. (1999) investigated the effect of formulation changes on the phase 
inversion dynamics and in vitro drug release properties of a PLGA-based drug delivery 
system by using optical microscopy, electron microscopy and high pressure liquid 
chromatography. Their results have shown that additives that accelerate the solution 
gelation rate at constant morphology result in high initial release rates, implying that 
drug diffusion through a tortuous two-phase gelled structure is faster than through a 
one-phase polymer solution. Conversely, additives that slow the rate of gelation 
dramatically reduce the initial drug release rate and lead to a more dense sponge like 
morphology.  
Narisawa et al. (1995) studied on the factors affecting the in vivo drug release. They 
used theophylline and propanolol hydrochloride (PPL) as model drugs. Drug release 
behaviors from two multiple unit types of controlled release systems were observed in 
the gastrointestinal (GI) tract of beagle dogs. They concluded that with respect to drug 
release from controlled-release preparations coated with insoluble polymer based film 
coating, a good in vitro/in vivo correlation was observed in the early stages of drug 
release, irrespective of drug properties, but solubility of the drugs was found to be an 
important factor that affected the drug release in the lower site of GI tract of dogs.  
Thombre et al. (1999a) demonstrated that the asymmetric membrane capsule can be 
used to deliver a poorly water soluble drug with a pH sensitive solubility such as 
glipizide. In order to obtain desired delivery duration, they solubilized the drug with the 
use of a pH-controlling excipient. Drug substances with a poor aqueous solubility were 
found to have very low rates, thus, the osmotic release rate of a drug from an 
asymmetric membrane capsule was found to depend on its solubility. They have shown 
that this limitation can be overcome for a drug such as glipizide, which has a pH-
dependent solubility, by including a solubility modifying excipient in the capsule core.  
In another study, Thombre et al. (1999b) describes a manual and a semi-automatic 
process developed for the manufacture of a novel non-disintegrating polymeric capsule. 
The capsule wall was made by a phase inversion process in which the membrane 
structure was precipitated on stainless steel mold pins by dipping the mold pins into a 
coating solution containing cellulose acetate-aceton-ethanol system. 
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In the following study, they used these capsules to describe the in vivo and in vitro drug 
release characteristics (Thombre et al., 1999c). They studied with phenylpropanolamine, 
chloropheniramine, trimazosin and theophylline as model drugs. The results of kinetic 
studies have shown that the asymmetric membrane capsule has a higher permeability 
that is consistent with the asymmetric structure of the capsule wall.  
Herbig et al. (1995) studied with asymmetric-membrane tablet coatings as in this study. 
They described the use of asymmetric-membrane coatings on pharmaceutical tablets. 
Trimazosin and doxazosin tablets were coated with cellulose acetate-acetone-formamide 
solution by dip-coating process and to demonstrate osmotic release, kinetic studies were 
conducted in water and MgSO4 solutions. Kinetic studies were also conducted on tablets 
coated with dense membrane and results have shown that release rate from the 
asymmetric membrane coated tablets was about 65 times higher than the release rate 
from the dense coated tablets. They changed the coating thickness and have found that 
overall membrane thickness has no effect on release rates. In addition, they varied 
glycerol content (used as nonsolvent) in the membrane solution and observed that 
increasing glycerol content leads to an increase in number and size of the macropores in 
the skin layer. 
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CHAPTER 4 
DIFFUSION IN ASYMMETRIC MEMBRANES 
4.1. Diffusion in Dense Membranes 
Transport through dense polymeric membranes in controlled-release systems occurs by 
a solution-diffusion process that is called as passive diffusion. The active agent must 
first dissolve in the membrane and then diffuse from the surface of high active 
ingredient concentration to the surface of low concentration.  
The active ingredient exists in a highly saturated state within the reservoir and is able to 
diffuse through the membrane in response to a gradient in thermodynamic activity. As 
long as the solution within the reservoir is saturated and sink conditions are maintained 
at the releasing film interface, the concentration gradient across the membrane remains 
constant and release of the drug follows zero-order kinetics (Cahn and Haasen, 1992). 
As a drug particle undergoes dissolution, the drug molecules on the surface are the first 
to enter into solution creating a saturated layer of drug-solution which envelopes the 
surface of the solid drug particle. This layer of solution is referred to as the diffusion 
layer. From this layer, the drug molecules pass throughout the dissolving fluid and make 
contact with the membranes. As the molecules of drug continue to leave the diffusion 
layer, the layer is replenished with dissolved drug from the surface of the drug particle 
(Ansel and Popovivch, 1990). 
4.2. Diffusion in Asymmetric Membranes 
The solution diffusion model described in Section 4.1 is easy to understand and 
valuable in practice. However, in asymmetric type membranes, mechanisms of the 
transport of components are much more complex. In a simple manner, asymmetric 
membranes can be regarded as a dual-zone system, consisting of very thin skin layer 
and a much thicker, porous sublayer. Usually, the transport mechanism of the skin is 
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assumed to obey the solution-diffusion model, whereas the porous support layer is 
considered as a system of capillaries arranged in parallel. 
Transport of molecules through the asymmetric membrane is influenced both by the 
transport resistance in the skin layer and the porous substrate. Simplified, the basic 
equation for mass transport of a permeating component in the asymmetric membrane 
can be written as follows; 
L
CCADRate eff 21 −=       (4.1) 
This equation is derived based on the assumption that steady-state condition is achieved 
in the membrane. Then, the concentration profile within the membrane is linear and 
time independent. Effective diffusivity, Deff, in equation 4.1 takes into accunt the 
presence of the pores and, thus, tortuous diffusional path that permeating molecules 
should follow. Concentration of permeating molecule at the boundaries of the 
membrane C1 and C2, can be related to the concentration within the surrounding 
medium through a linear equilibrium relationship as follows; 
C1=KC1*   C2=KC2*    (4.2) 
If equation 4.2 is inserted into equation 4.1, then  
( )
L
CCKADRate eff
**
21 −
=     (4.3) 
where, the product of the effective diffusivity of the solute across the membrane, Deff, 
and the partition coefficient of the solute between the membrane and the adjacent phase, 
K, is defined as the effective permeability of the membrane, Peff 
Peff = Deff K       (4.4) 
The effect of the transport resistance of dense skin layer and the porous sublayer on 
permeation characteristics can be demonstrated by the resistance model which was first 
demonstrated by Henis and Tripodi (1992). According to this model, the mass flow can 
be considered analogous to an electrical flow in a circuit consisting of three resistance 
components in a series-parallel configuration as shown in Figure 4.1. 
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Figure 4.1. Schematic cross section of an asymmetric membrane and the mass transport 
resistance configuration. 
The overall permeation resistance Rt is given by 
Rt = R1 + R2 R3 / (R2 + R3)    (4.5) 
where R1 is the resistance of the skin layer; R2 and R3 are the resistances of the pores 
and the polymer matrix, respectively. These resistances can be written as 
R1 = AP
L
eff 1
1      (4.6) 
R2 = 
εAP
L
eff 2
2      (4.7) 
R3 = )1(1
2
ε−AP
L
eff
    (4.8) 
where L1 and L2 are the thickness of the skin layer and the substrate, respectively; Peff,1 
and Peff,2 are the effective permeability coefficients through the polymer matrix and the 
pores, respectively and ε  is the area porosity of the substrate. 
4.3. Diaphragm Cell Model 
The permeability of porous membranes can be determined using the diaphragm cell 
model (Cussler, 1997). In this model, it is assumed that the steady-state condition is 
reached in the membrane even though concentrations in the adjacent compartments 
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change with time. This is a reasonable assumption since the membrane has a much 
smaller volume than the adjacent compartments. In this steady state, the rate of mass 
transfer across the membrane is given by equation 4.3. If the adjacent compartments 
next to upper and lower side of the membrane are referred to as donor and receiver 
compartments and corresponding concentrations are denoted as CD and CR, respectively, 
then equation 4.3 is rewritten as follows; 
( )RDeff CCL
APRate −=      (4.9) 
The overall mass balances on the donor and receiver compartments are as follows; 
VD ( )RDeffD CCL
APdt
dc
−−=     (4.10) 
VR ( )RDeffR CCL
APdt
dc
−=      (4.11) 
where VD and VR are the liquid volumes in the donor and receiver compartments, 
respectively, (cm3), t is time (s) and A is the surface area of the membrane. If equation 
4.11 is subtracted from equation 4.10, then,  
( ) ( )RDeffRD ccPccdt
d
−−=− β     (4.12) 
where β is a geometric constant characteristic of the diffusion cell, defined as 



+=
RD VVL
A 11β      (4.13) 
The differential equation is subjected to the initial condition 
at t=0,   cD-cR = cD0-cR0    (4.14) 
where, cD0 and cR0 are the initial concentrations in the donor and receiver, respectively. 
Integrating the flux equation subject to this initial condition gives the result 
ln tPcc
cc
eff
RD
RD β=



−
−
00
    (4.15) 
If it is assumed that there is no accumulation in the membrane,  
mtot = cD0 VD + cR0 VR = cD VD + cR VR     (4.16) 
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and combining equations 4.15 and 4.16, functional time dependence of the 
concentrations in the donor and the receiver can be obtained as follows (Ristic, 2000). 
cD = ( ) ( )[ ]tPccc
V
V
V
V
c
effRDR
R
D
D
R
D β−−+
+
+

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cR = ( ) ( )[ ]tPccc
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CHAPTER 5 
STATISTICAL DESIGN AND ANALYSIS OF EXPERIMENTS 
Experimental design is an important tool in engineering for improving the performance 
of a manufacturing process. The use of experimental design can result in products, 
which are easier to manufacture, products that have enhanced field performance and 
reliability, lower product cost, and shorter product design and development time.  
Statistical design of experiments refers to the process of planning the experiment. 
Collected appropriate data can be analyzed by statistical methods, resulting in valid and 
objective conclusions. If meaningful conclusions from the data are desired, the 
statistical approach is necessary. When the problem involves data that are subject to 
experimental errors, statistical methodology is the only objective approach to analysis. 
Thus, there are two aspects to any experimental problem: the design of the experiment 
and the statistical analysis of the data. These two parts are related because the method of 
analysis depends on the design employed.  
The first step in the design of any experiment is determining which factors      
affect the response in a characterization experiment. A logical next step is to optimize, 
that is, to determine region in the important factors that leads to the best possible 
response. 
5.1. Experimental Designs for Fitting Response Surfaces 
Response surface methodology is commonly used and very useful for the modeling and 
analysis of problems in which response is influenced by several variables, and, the 
objective is to optimize the response. If y denotes the response affected by “k” 
parameters, then,  
y = f ( x1, x2, ….xk ) + ε    (5.1) 
where ε represents the noise or error observed in the response y. If the expected 
response E (y) = f ( x1, x2, ….xk ) = η , then the surface represented by 
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η = f ( x1, x2, ….xk )     (5.2) 
is called as a response surface. The proper choice of an experimental design plays an 
important role in fitting and analyzing response surfaces. The suitable experimental 
design should 
a) provide a reasonable distribution of data points 
b) allow experiments to be performed in blocks 
c) allow new designs of higher order, i.e., allow to increase number of 
experiments 
d) does not require large number of experimental runs 
e) allow to fit data to known models 
f) provide precise estimates of the model coefficients 
g) does not require too many levels of independent variables 
There are many response surface design methods available in the literature. In all these 
techniques, the idea is to generate the design points that are equidistant from a specified 
origin. A brief summary of design techniques is listed below: (Montgomery, 2001). 
1) The orthogonal first-order design: 
This type of designs include the 2k factorial and fractions of the 2k series in which k is 
the number of design variables. The data is fitted to first order model. 
2) The central composite design (CCD): 
It is a very efficient design for fitting the second-order model. Depending on the 
geometric shape of the region of interest, variations of the central composite design 
such as phase-central composite design or the phase-centered cube or the Box-Behnken 
design are used. 
3) Computer-generated (optimal) design: 
If the experimental region is not either a cube or a sphere, then standard response 
surface designs will not be applicable. In these cases, computer-generated designs are 
usually used. 
4) Robust parameter design: 
In this approach, the variables in a process or product are classified as either control 
(controllable) variables or noise (or uncontrollable) variables. The settings for the 
controllable variables are found that minimize the variations transmitted to the response 
from the uncontrollable variables.  
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5) Mixture design: 
This type of design is used when all variables influencing the response are not 
independent and will be discussed in detail in the next section. 
5.2. Mixture Design 
In some experimental situations the factors cannot be varied independently of each 
other. Many products are manufactured by mixing together two or more ingredients or 
components. 
In mixture experiments, the factors are the components or ingredients of a mixture, and 
consequently their levels are not independent. For example, if x1, x2, …, xp denote the 
proportions of p components of a mixture, then  
0 ≤  xi ≤  1  i= 1,2…, p     (5.3) 
and 
x1 + x2 + …+ xp = 1  (i.e., 100 percent)  (5.4) 
For a two-component system, the mixture space is a rectangle, while, with three 
components, the mixture space is a triangle with vertices corresponding to pure 
components. 
When there is no constraint on the individual components in the mixture, simplex 
designs are used to study the effects of mixture on components on the response variable. 
If the mixture contains p components and the experimental design points take m+1 
equally spaced values from 0 to 1, then  
1210 ...,.........,, mmXi =   i=1,2,……….,p  (5.5) 
In general, the number of points in a {p,m} simplex lattice design is  
( )
( )!!
!
1
1
−
−+
= pm
mpN       (5.6) 
Figure 5.1 shows the experimental design points in a {3,3} simplex lattice.  
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In some mixture problems, constraints on the individual components arise. If there is 
only lower bound constraint 
1≤≤ ii xl    i=1,2…,p    (5.7) 
simplex design can still be used by defining pseudocomponents, defined as  

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j
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i
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l       (5.8) 
with 1
1
<∑
=
p
j
jl . Then sum of compositions of pseudocomponents is equal to 1, ∑
=
=
p
i
ı
ix
1
1. 
 
Figure 5.1. Simplex lattice design for a ternary mixture. 
If the components have both upper and lower bound constraints, then the design does no 
longer have a standard shape. For these types of mixture problems, computer generated 
designs are used.  
5.3. Mixture Models 
Mixture models are usually different from the usual polynomials employed in fitting the 
response surface of other design problems. Mixture models commonly used in the 
literature are listed as follows. 
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CHAPTER 6 
EXPERIMENTAL 
In this thesis experimental study consists of five parts: 
- Tablet preparation 
- Tablet coating 
- Dissolution studies 
- Permeability studies 
- Characterization 
And this chapter discusses the details of experimental procedures. 
6.1. Properties of Polymer and Model Drug 
Throughout this study, theophylline anhydrate and cellulose acetate were used as a 
model drug and membrane forming polymer respectively. Theophylline anhydrate was 
kindly supplied by Eczacıbaşı A.Ş.  
Theophylline is structurally classified as a methylxanthine. It occurs as a white, 
odorless, crystalline powder with a bitter taste. Figure 6.1 shows the crystalline structure 
of theophylline. Anhydrous theophylline has the chemical name 1H-Purine-2, 6- dione, 
3, 7 –dihydro-1, 3- dimethyl. 
 
Figure 6.1. SEM picture of crystalline theophylline anhydrate. 
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1 g of theophylline dissolves in 120 ml of water. Anhydrate form is more soluble than 
hydrate form (Karasulu, 1996). The molecular formula of anhydrous theophylline is 
C7H8N4O2 with a molecular weight of 180.17 and molecular structure is shown in 
Figure 6.2.  
 
Figure 6.2. Molecular structure of theophylline. 
Theophylline is used for the treatment of the chronic asthma and other chronic lung 
diseases symptoms and reversible airflow obstruction. 
Cellulose acetate that is an ester of cellulose and acetic acid, is white, odorless and non-
toxic, natural thermoplastic polymer. Figure 6.3. shows the molecular structure of the 
cellulose. 
 
Figure 6.3. Molecular structure of cellulose. 
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Cellulose acetate is the generic term used to describe a variety of acetylated cellulose 
polymers. This includes cellulose diacetate, cellulose triacetate and the mixed esters of 
cellulose acetate propionate and cellulose acetate butyrate. Cellulose diacetate and 
cellulose triacetate are acetylated on one, two or all three of the available sites on each 
glycopyranose ring. The degree of substitution, along with the solvents used during the 
manufacturing process, determine the composition and properties of the acetate 
produced. 
6.2. Tablet Preparation 
Tablets are solid dosage forms of medicinal substances usually prepared with the aid of 
suitable pharmaceutical adjuncts. Tablets may vary in size, shape, weight, hardness, 
thickness, disintegration characteristics, and in other aspects, depending upon their 
intended use and method of manufacture.  
In this study, tablets were prepared by compressing powder form of the drug with the 
use of hydraulic press operated at 110 MPa pressure. Stainless steel die with a diameter 
of 1.2 cm was used to produce 400 mg drug tablets having cylindrical shapes. 
6.3. Tablet Coating 
6.3.1. Preparation of Membrane Solution 
Tablets prepared by compression of drug were coated with ternary solution consisting 
of polymer, solvent and nonsolvent. Polymer is completely soluble in solvent and has 
partial solubility in nonsolvent. Membrane solutions were prepared by completely 
dissolving the polymer in solvent and then adding nonsolvent to the homogeneous 
binary mixture. Tablets were coated with different solutions prepared by dissolving 
cellulose acetate in  
a) different nonsolvents with the same polymer-solvent and nonsolvent ratios, 
b) the same solvent and nonsolvent with different polymer-solvent and 
polymer-nonsolvent ratios. 
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The properties of chemicals and their compositions used in the preparation of 
membrane solutions are given in Table 6.1. 
Table 6.1. Properties of chemicals used for drug-release experiments. 
Materials Specifications 
Cellulose Acetate 
39.7 wt % acetyl content 
Average Mn 50,000 (GPC) 
Aldrich 
Acetone 
( CH3COCH3 ) 
99% , M= 58.08 g/mol, d= 0.79 kg/l 
Merck 
Formamide 
( HCONH2 ) 
99.5% , M= 45.04 g/mol, d= 1.13 kg/l 
Merck 
1- Octanol 
( C8H18O ) 
99%, M= 130.23 g/mol, d= 0.83 kg/l 
Merck 
Potassium Dihydrogen Phosphate 
( KH2PO4 ) 
M= 136.09 g/mol 
Merck 
Sodium Hydroxide Pellets 
( NaOH ) 
M= 40.00 g/mol 
Merck 
1-Hexanol 
(CH3(CH2)5OH) 
98%, d= 0.814 kg/l 
Aldrich 
Glycerol 87%, d= 1.23 kg/l Merck 
Phosphoric Acid 
( H3PO4 ) 
85.2% 
Sigma 
6.3.2. Dip-Coating 
Tablets were coated by dipping them in the polymer solution followed by rotation and 
drying in ambient conditions. The coating process places a thin tight coating over the 
compressed tablets.  
6.4. Dissolution Studies  
The process by which a drug particle dissolves is termed dissolution and the rate at 
which it dissolves in medium is referred to as its dissolution rate. Dissolution testing is 
used in product development to assist in selection of a candidate formulation, in 
research to detect the influence of critical manufacturing variables such as binder effect, 
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mixing effect, coating parameters, types of drug, and as a quality control procedure in 
pharmaceutical production.  
 
Figure 6.4. Dissolution test apparatus. 
In this study, the in vitro dissolution studies were performed using the United States 
Pharmacopeia XXIII (USP XXIII) dissolution methodology. According to this standard, 
900 ml of dissolution medium was placed in the vessel and temperature was allowed to 
come 37 0C using a constant temperature bath. Then, the single tablet to be tested was 
immersed in the vessel and the solution was stirred with a mixer adjusted at 50 rpm. The 
dissolution test apparatus was designed according to USP standards and is shown in 
Figure 6.4. 
Under normal circumstances, a drug may be expected to remain in stomach for 2 to 4 
hours (gastric emptying time) and in the small intestines for 4 to 10 hours. The pH of 
the stomach varies from 1 to 3 and in ascending colon this value is between pH 7 and 
pH 8. To simulate actual dissolution environment in the body, the pH of the dissolution 
medium was kept at 3 during the first 3.5 hours of dissolution test, then, it was increased 
to 7.4 and was kept at that value until the end of the test. In the preparation of the 
dissolution medium, 8.5 v% phosphoric acid was added to the 900 ml distilled water to 
reduce pH to the value of 3. After 3.5 hours, the pH of the medium was increased to 7.4 
by adding 5.3 M NaOH to the solution. During 5 hours of dissolution test, samples were 
taken from the dissolution medium at certain times and concentration of drug in the 
release medium was determined by spectrophotometer (Shimadzu, UV-1601). The peak 
for theophylline anhydrate is observed at 272 nm wavelength. Each dissolution test was 
conducted on three tablets and the mean of the results was calculated. The UV spectrum 
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and the calibration curves of theophylline anhydrate prepared in three different solutions 
are shown in Appendix A and B in Figures A1 through B3, respectively. 
6.5. Permeability Studies 
To investigate the permeation characteristics of membranes, diffusion cell shown in 
Figure 6.5 was designed. The diffusion cell consists of two compartments, the upper 
one is  a donor compartment and the lower one is a receiver compartment. 
 
Figure 6.5. Schematic representation of diffusion cell. 
The glass tube with a diameter of 2.5 cm acts as the donor compartment while the 
beaker with a diameter of 8 cm acts as the receiver compartment. The position of the 
glass tube in the beaker is fixed using rubber plugs. The membrane is tightly sealed at 
the bottom of the glass tube, which has open ends. A constant temperature is maintained 
during the experiment by means of water circulation in the jacket surrounding the 
beaker. Mixing in the receiver compartment is provided by magnetic stir bar. During the 
experiment, the donor compartment is filled with 10 ml theophylline solution with an 
initial concentration of 7 mg/ml while the receiver compartment is filled with 50 ml 
phosphate buffer solution with a pH of 3. Temperature in both compartments is kept 
constant at 37 0C. During 5 hours, 10 µL samples were taken periodically from both 
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compartments to monitor the change in drug concentration with time. Concentration of 
theophylline was determined using UV spectrophotometer.  
6.6. Characterization 
In this part of the study the morphology of the casted films was investigated by 
scanning electron microscopy (Philips, XL-30SFG) and the phase analysis was 
conducted by using the program analySIS 2.1 of scanning electron microscopy system. 
The gray level difference between polymer matrix and the pores were used. Each phase 
was represented by different gray level and according to these different gray values the 
percentage of each phase was calculated by the program. 
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CHAPTER 7 
RESULTS AND DISCUSSION 
This chapter was divided into three parts that covers the results of the dissolution 
studies, along with morphological studies, permeability studies and statistical analysis. 
In dissolution studies, drug release rates from the asymmetric and dense membrane 
coated tablets were compared to assess the performance of asymmetric membranes. The 
effects of polymer/solvent (P/S), polymer/nonsolvent (P/NS) and solvent/nonsolvent 
(S/NS) ratios, number of coating layer, coating time, and evaporation conditions on 
release rate of the drug were investigated. Additionally, different types of nonsolvents 
were tried in the preparation of membrane solutions and their effects on release rate 
were compared.  
In permeability studies, permeation characteristics of the membranes cast from ternary 
solutions were investigated. The results of statistical analysis were shown both in 
tabular and graphical form, which allow to determine optimum response in the design 
area.  
In morphological studies, scanning electron microscope (SEM) pictures of different 
types of membranes were analyzed to determine overall thickness, skin layer thickness, 
pore sizes and porosity.  
7.1. Dissolution and Morphological Studies 
Dissolution studies on tablets coated with asymmetric type membranes were conducted 
to determine the release rate of drug, as well as the release kinetics. For this purpose, the 
graph of concentration of drug in the dissolution medium as a function of time was 
analyzed by fitting the experimental data to a linear equation of the form y = ax. The 
release rate of theophylline was calculated by multiplying the slope of the linear line (a) 
with the volume of the dissolution medium. The regression coefficient, R2, indicates the 
accuracy or perfectness of linear fit to the experimental data. The release rate of 
theophylline from tablets coated with membrane solutions consisting of cellulose 
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acetate (CA), acetone (Ac), water (W) and corresponding R2 values are tabulated in 
Table 7.1.  
Table 7.1. Release rates and characterization of membranes prepared for dissolution 
studies. 
Composition 
CA Ac W 
Porosity 
(%) 
Total 
Thickness 
(µm) 
Skin 
Thickness 
(µm) 
Average 
Pore Size 
(µm) 
Release 
Rate 
(mg/min) 
R2 
10 90 0 Dense 8.40 - 0.383 0.0090 0.9802 
10 80 10 22.33 16.05 1.14 1.040 0.0630 0.9454 
5 80 15 27.40 10.52 0.63 0.885 0.1800 0.9752 
15 80 5 16.48 15.27 5.00 0.670 0.0036 0.9607 
5 85 10 26.09 133.95 - 19.925 0.1800 0.9963 
15 75 10 33.00 20.06 1.85 1.110 0.0180 0.9893 
15 70 15 28.44 34.91 2.58 1.220 0.0081 0.9978 
3 80 17 34.19 13.69 - 1.100 0.7200 0.9700 
5 90 5 - 6.46 - 0.970 0.2700 0.9500 
10 85 5 - 13.13 - - 0.0450 0.9755 
10 75 15 56.24 30.32 0.61 1.160 0.0540 0.9962 
One of the goals in developing a controlled release system is to provide zero-order 
release kinetics since, in this case, the release rate remains constant, independent of 
drug remaining as shown in equation 7.1. 
===
0kCdt
dmVdt
dC constant   (7.1) 
According to equation 7.1, the requirement to obtain zero-order release kinetics is to 
observe a linear release profile with respect to time. This goal was reached for all tablet 
coatings prepared in this study since R2 values close to one obtained for each 
dissolution experiment indicate linear relationship between concentration of drug in the 
dissolution medium and time.  
Morphological studies were conducted on films cast from solutions having the same 
compositions as those used in coating the tablets. Initial casting thickness of all the 
membranes is 300 µm. SEM pictures of these films were taken to determine overall 
thickness, skin layer thickness, average pore sizes as well as the porosity. In these 
pictures, gray parts represent the polymer matrix, while the black parts are porous 
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regions. Phase analyses were conducted by using analySIS 2.1 and the results were 
shown in Table 7.1. 
The results of dissolution studies and phase analysis were used to calculate resistances 
of the skin layer and the substrate as well as the individual resistances of the polymer 
matrix and the pores in the substrate. The values are listed in Table 7.2. It can be 
noticed from equation 7.2 that the ratio of total resistance of dense coating (Rtotal, dense) to 
that of the asymmetric coating (Rtotal, asymmetric) is equal to the ratio of release rate of 
asymmetric membrane to the release of dense membrane. 
dense
asymmetric
asymmetrictotal
densetotal
Rate
Rate
R
R
=
,
,     (7.2) 
The total resistance of dense coating was calculated from equation 7.3 using 
experimentally measured permeability as well as the thickness and area of the 
membrane. 
AreaP
LR
dense
total
densetotal =,      (7.3) 
Then, total resistance of asymmetric coating was calculated from equation 7.2 using 
release rates listed in Table 7.1. 
Table 7.2 Calculated resistances of skin layer, substrate, polymer and pores of the 
membranes 
Composition 
CA Ac W Rskin Rsubtrate Rpolymer Rpore 
10 80 10 32.6 1.7 548.6 1.7 
5 80 15 18.0 * 389.3 * 
15 80 5 142.9 457.2 351.4 * 
5 85 10 40.0 * 5124.9 * 
15 75 10 52.9 67.2 776.7 73.5 
15 70 15 73.7 193.0 1291.0 226.9 
3 80 17 * 3.0 594.5 3.0 
5 90 5 * 8.0 184.6 8.4 
10 85 5 * 48.0 375.2 55.1 
10 75 15 17.4 22.6 1940.1 22.8 
 * These values could not be calculated. 
The effect of skin layer and substrate resistances on the total resistance was ascertained 
using the resistance model discussed in Chapter 4. According to this model, the 
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resistance of skin layer (Rskin) was determined from equation 4.6 and the resistance of 
substructure was calculated by subtracting the skin layer resistance from the total 
resistance. The resistances of the pores (Rpore) and polymer matrix (Rpolymer) in the 
porous substrate were calculated using equation 4.7 and 4.8, respectively. 
7.1.1. Comparison of the Drug Release Rates of Dense and Asymmetric Membrane 
Coated Tablets  
Dissolution kinetics of the dense and the asymmetric-membrane coated tablets were 
determined to compare the drug release rates of these membranes. The dense coating 
was applied by dip-coating the tablet in a solution consisting of 10% cellulose acetate 
dissolved in acetone, whereas the asymmetric coating was obtained by dipping the 
tablet in a solution consisting of 10% cellulose acetate, 80% acetone and 10% water. 
The release profiles for both types of coated tablets are shown in Figure 7.1. 
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Figure 7.1. Release of theophylline from tablets coated with dense and asymmetric-
membrane coatings. 
The release rate from the asymmetric-membrane coated tablet was about 7 times higher 
than the release rate from the dense-coated tablet. This is due to the fact that in dense-
coating, diffusional resistance to transport of the drug occurs through the overall 
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thickness while in asymmetric coating most of the resistance to transport is in the thin 
skin rather than in the porous substrate. Higher drug release rate from asymmetric 
membrane coating is expected when SEM pictures of these two types of membranes 
shown in Figure 7.2 and Figure 7.3 are compared. 
 
Figure 7.2. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Water. Magnificationx5000. 
 
Figure 7.3. SEM picture of cross section of a membrane. Initial composition: 
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10% CA, 90% Acetone. Magnificationx10000. 
Figure 7.2 indicates that membrane cast from ternary solution of polymer (CA), solvent 
(acetone) and nonsolvent (water) has an asymmetric structure. In this figure, dense layer 
is facing to the top of the picture while porous layer is at the bottom. Porous layer has a 
sponge like structure and pores are interconnected. This is a desired structure since it 
leads to high permeabilities. The overall thickness of the membrane is 16.05 µm while 
the thickness of the skin layer is only 1.14 µm. The porosity and average pore size were 
determined as 22.3% and 1.04 µm, respectively. 
The membrane cast from binary mixture of CA and acetone has a dense symmetric 
structure as shown in Figure 7.3. The average total thickness and the average pore size 
were determined as 8.4 µm and 0.383 µm, respectively. Pores in the asymmetric 
membrane are almost three times larger than those in dense membrane. Thus, the 
substrate resistance of the asymmetric membrane is only 5% of the total resistance 
calculated from the ratio of Rsubstrate/Rtotal and mass transport of drug molecules is 
mainly controlled by diffusion in thin skin layer that is only 7.1% of the total thickness. 
Since the thickness of skin layer of the asymmetric membrane is smaller than the 
overall thickness of the dense membrane, lower drug release rate was obtained from 
dense membrane.  
7.1.2. Effect of Polymer / Solvent (P/S) Ratio on Release Rate 
To investigate the effect of polymer-solvent ratio (P/S) on drug release rate, tablets were 
coated with solutions consisting of three different nonsolvent composition which are 5% 
water and 15/80, 5/90 and 10/85 P/S ratios, 10 % water and 5/85, 10/80, 15/75 P/S 
ratios and finally 15% water and 5/80, 15/70 and 10/75 P/S ratios. 
The release rate of theophylline as a function of P/S ratio for three different nonsolvent 
compositions is shown in Figure 7.4. 
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Figure 7.4. Release rate of theophylline as a function of P/S ratios for 5% 10% and 15% 
water content. 
The release rates of tablets prepared from 5% water decreases exponentially with 
increasing P/S ratios, due to increasing resistance to transport of theophylline molecules 
and the change in morphology of the membranes. With decreasing P/S ratio the change 
in morphology from a dense structure to a porous one was observed from SEM pictures 
as shown in Figure 7.5 through 7.7. 
 
Figure 7.5. SEM picture of cross section of a membrane. Initial composition: 
15% CA, 80% Acetone, 5% Water. Magnificationx5000. 
  44 
 
Figure 7.6. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 85% Acetone, 5% Water. Magnificationx5000. 
 
Figure 7.7. SEM picture of cross section of a membrane. Initial composition: 
5% CA, 90% Acetone, 5% Water. Magnificationx10000. 
The membrane prepared from the solution having highest P/S ratio (15/80) and the 
lowest drug release rate has the highest total and skin layer thickness, 15.27 µm and 
 5 µm, respectively, because of the high polymer concentration. Figure 7.7 indicates that 
membrane prepared from low polymer concentration (P/S = 5/90) has a porous structure 
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in which sponge like cylindrical pores with a wide  pore  size distribution was 
 observed. 
The release rate of membranes prepared from solutions including 10% and 15% water 
also decreases with increasing P/S ratio. SEM picture of the membrane prepared from 
the lowest P/S ratio of 5/85 is shown in Figure 7.8.  
 
Figure 7.8. SEM picture of cross section of a membrane. Initial composition: 
5% CA, 85% Acetone, 10% Water. Magnificationx500. 
 
Figure 7.9. SEM picture of cross section of a membrane. Initial composition: 
15% CA, 75% Acetone, 10% Water. Magnificationx4000. 
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The total thickness of this membrane, 133.9 µm, is much higher than the thickness of 
other membranes due to the presence of macropores having average size of 19.9 µm. 
The average pore size of the pores at the bottom of the picture corresponding to dense 
skin layer decreases to 630 nm. This membrane has the highest release rate since the 
presence of macropores significantly decreased the total resistance of the membrane. 
When P/S ratio is increased from 5/85 to 10/80 and then to 15/75, macropores disappear 
as shown in Figure 7.2 and Figure 7.9, respectively. In the membrane prepared from the 
solution consisting of P/S ratio of 10/80, the total resistance of the membrane is 
controlled by the resistance of the skin layer as indicated by the ratio of 
Rskin/Rsubstrate=19. However, when P/S ratio is increased to 15/75, then, both the 
resistances of the skin layer and the substrate contribute to the overall resistance to 
transport of drug molecules (Rskin/Rsubstrate=52.8/67.2=0.79). Consequently the release 
rate significantly decreases as P/S ratio is decreased from 10/80 to 15/75.  
The same relationship between the release rate and the P/S ratio was observed when 
composition of water in the solution was increased to 15%. SEM pictures of the 
membranes having initial P/S ratio of 5/80, 10/75 and 15/70 are shown in Figures 7.10 
through 7.12.  
 
Figure 7.10. SEM picture of cross section of a membrane. Initial composition: 
5% CA, 80% Acetone, 15% Water. Magnificationx10000. 
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Figure 7.11. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 75% Acetone, 15% Water. Magnificationx10000. 
 
Figure 7.12. SEM picture of cross section of a membrane. Initial composition: 
15% CA, 70% Acetone, 15% Water. Magnificationx10000. 
The membrane prepared from the lowest polymer concentration of 5%, is very thin 
compared to the other membranes. From SEM picture shown in Figure 7.10, the overall 
thickness and the average pore size were determined as 10.52 µm and 0.885 µm, 
respectively. The overall resistance of this thin membrane is lower than the others, thus, 
the highest release rate was observed for the lowest P/S ratio of 5/85. When the initial 
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P/S ratio is increased to 10/75, average pore size increases to 1.16 µm. It was 
determined from Figure 7.11 that, membrane has uniform sponge type cylindrical pores 
with a narrow pore size distribution. The membrane prepared from the initial P/S ratio 
of 15/70 has also sponge like substructure, however, pore size distribution is wider than 
the membrane having P/S ratio of 10/75, as shown in Figure 7.12. In the membrane 
prepared from the initial P/S ratio of 10/75, the decrease in release rate as P/S ratio is 
increased from 10/75 to 15/70 is associated with both the change in pore size 
distribution from narrow to wide and the increase in both the resistance of the skin layer 
and the substrate. Consequently, the drug release rate decreases significantly with an 
increase in overall resistance to passage of drug molecules.  
7.1.3. Effect of Polymer / Nonsolvent (P/NS) Ratio on Release Rate 
To investigate the effect of P/NS ratio on drug release rate, tablets were coated with 
solutions consisting of 80 w% acetone and 15/5, 10/10, 5/15 and 3/17 P/NS ratios.  
Figure 7.13 shows that release rate exponentially decreases with increasing P/NS ratio.  
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Figure 7.13. Release rate of theophylline as a function of P/NS ratio for 80% acetone 
content.  
SEM picture of the membrane prepared from the lowest polymer composition, 3% CA, 
is shown in Figure 7.14. 
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Figure 7.14. SEM picture of cross section of a membrane. Initial composition: 
3% CA, 80% Acetone, 17% Water. Magnificationx5000. 
This membrane has the highest drug release rate since it has almost no dense skin layer 
and thus its porosity is higher than the others. It has a porous structure with irregular 
pore shapes. The decrease in release rate with increase in P/NS ratio from 0.18 to 3 is 
associated with the decrease in porosity of the membrane from 34% to 16.5%. The 
change in morphology of the membranes with increasing P/NS ratio can be seen in 
Figures 7.14, 7.10, 7.2, 7.5, respectively. The increase in P/NS ratio also leads to an 
increase in contribution of the resistance of the substrate layer. The fraction of the skin 
layer resistance (Rskin/Rtotal) decreases from 0.95 to 0.23 as P/NS ratio is increased from 
1 to 3. This is an expected result, since with a decrease in porosity of the membrane, 
amount of polymer and its corresponding resistance in the substructure increases 
leading to increase in contribution of the substrate resistance.  
7.1.4. Effect of Solvent / Nonsolvent (S/NS) Ratio on Release Rate 
The effect of solvent-nonsolvent ratio was investigated by coating the tablets with 
polymer solutions consisting of 10% cellulose acetate and 85/5, 75/15 and 80/10 and 
finally 15% cellulose acetate and 80/5, 70/15, and 75/10. Figure 7.15 shows the effect 
of S/NS ratio on the release rate with different polymer contents. 
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Figure 7.15. Release rate of theophylline as a function of S/NS ratio for 10% and 15% 
polymer content. 
According to Figure 7.15 a maximum in release rate was observed with increasing S/NS 
ratio. When polymer composition is 10%, an increase in release rate was observed by 
increasing S/NS ratio from 75/15 to 80/10 due to a decrease in contribution of substrate 
resistance. The ratio of resistance of the skin layer to that of the substrate, Rskin/Rsubstrate, 
increases from 0.77 to 19 as S/NS is varied from 75/15 to 80/10. Hence, in the 
membrane, prepared from 10% CA, 80% acetone, 10% water, total resistance is very 
small which occurs only 7% of the overall thickness. As a result, this membrane shows 
the maximum release rate. Further increase in S/NS ratio from 80/10 to 85/5 leads to a 
change in morphology from more porous to a dense one as shown in Figure 7.2 and 7.6, 
respectively.  
Similarly, when polymer composition is 15%, release rate increases and reaches to the 
maximum as S/NS ratio was increased from 70/15 to 75/10 and then starts to decrease 
as S/NS ratio was increased further to 80/5. This is due to changes in effect of 
individual resistances on the overall resistance. At low S/NS ratios, the resistance of the 
skin layer becomes more dominant, thus, with increasing S/NS ratios the release rate 
increases. However, at high S/NS ratios, the resistance of the substrate layer increases 
with increasing S/NS ratios leading to decrease in the release rates. Consequently, the 
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balance between the resistance of the skin layer and the resistance of the sublayer 
causes an observation of the maximum in the release rates. 
7.1.5. Effect of Number of Coatings on Release Rate 
The effect of number of coatings on release rate was investigated by coating the tablets 
1,2 and 3 times with the solution consisting of 10 w% cellulose acetate, 80 w% acetone 
and 10 w% water. Dipping time for each coating was 60 sec. Results of the effect of 
number of coatings on the release rate are shown in Figure 7.16.  
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Figure 7.16. Release of theophylline from tablets coated with asymmetric membrane  
1, 2 and 3 times.  
The decrease in release rate with increasing number of coating is an expected result 
since resistance to transport of drug and water molecules increases with increasing the 
length of diffusion path. The rate of drug release from a tablet coated once is almost 15 
times higher than the tablet coated 3 times. 
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7.1.6. Effect of Coating Time on Release Rate 
The effect of coating time on release rate was investigated by coating the tablets with 
two different dipping times, which are 1 and 2 min with the solution consisting of 10 
w% cellulose acetate, 80 w% acetone and 10 w% water. The release profiles are shown 
in Figure 7.17. 
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Figure 7.17. Release of theophylline from tablets coated with asymmetric membrane 
with coating times 1 and 2 min. 
The rates of drug release from a tablet coated for 1 and 2 min were calculated as 0.063 
and 0.036 mg/min, respectively. The decrease in release rate with increasing the coating 
time is due to an increase in the amount of coating solution on the tablet that leads to 
increase in the total thickness and the skin thickness.  
7.1.7. Effect of Evaporation Conditions on Release Rate 
To investigate the effect of evaporation on the release rate, tablets were coated with 
10% CA, 80% acetone and 10% water and then dried under free and forced convection 
conditions. The release profiles of both types of coated tablets are shown in Figure 7.18.  
R2 = 0,9964 
R2 = 0,9387 
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Figure 7.18. Release of theophylline from tablets in which the solvent is evaporated 
under free and forced convection condition. 
The membrane prepared under forced convection condition was transparent indicated 
that phase separation could not be achieved. This hypothesis was supported by the SEM 
picture of the membrane shown in Figure 7.19. 
 
Figure 7.19. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Water under forced convection 
condition. Magnificationx15000. 
R2 = 0,9699 
R2 = 0,9454 
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The membrane is completely dense and no porous region is observed while the 
membrane cast from the same initial composition but dried under free convection 
conditions has a porous asymmetric structure with 7.1% skin layer as shown previously 
in Figure 7.2. The change in structure from porous/asymmetric to a dense one leads to a 
drop in release rate from 0.063 mg/min to 0.045 mg/min.  
The membrane formation process is very complex influenced by both thermodynamic 
and kinetic factors. When the speed of air in the drying atmosphere is increased, the rate 
of evaporation of solvent increases dramatically and within a short time, its 
concentration at the free surface of the membrane solution drops to zero. This leads to 
very strong diffusional resistance within the membrane and slow evaporation of the 
nonsolvent. Consequently two phase region boundary is never reached and the resulting 
membrane structure becomes dense due to the lack of phase separation. 
The results shown in Figure 7.18 suggest that evaporation step during membrane 
preparation has a significant effect on the resulting membrane structure. Simply, by 
varying the evaporation condition, membranes with totally different structures can be 
produced from the same polymer/solvent/nonsolvent combination. 
7.1.8. Effect of Types of Nonsolvent on Release Rate 
To investigate the effect of nonsolvent type on the release rate, tablets were coated with 
solutions consisted of 10% CA, 80% Ac and 10% nonsolvent which were water, 
formamide, 1-octanol, glycerol and 1-hexanol. The effect of nonsolvent type on the 
release rate of theophylline is illustrated in Figure 7.20. To examine the morphology of 
the membranes and its effect on the release rate, SEM pictures were taken as shown in 
Figures 7.21 through 7.27. The phase analysis was conducted on each membrane and 
the results are listed in Table 7.3. 
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Table 7.3. The release rate and the results of phase analysis of the membranes prepared from 
different nonsolvents. 
Nonsolvent 
Release 
Rate 
(mg/min) 
R2 Porosity (%) 
Ltotal 
(µm) 
Lskin 
(µm) 
Average 
Pore Size 
(µm) 
Skin % 
Octanol 0.360 0.9590 17.01 32.92 1.57 0.50 4.7 
Water 0.063 0.9454 22.33 16.05 1.14 1.04 7.1 
Formamide 0.036 0.9812 Dense 12.84 1.60 0.53 12.4 
Glycerol 0.036 0.9830 37.73 39.56 4.83 16.78 12.2 
Hexanol 0.027 0.9604 44.00 24.90 3.35 1.24 13.4 
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Figure 7.20. The release of theophylline from tablet coatings prepared from 
CA/Acetone and different nonsolvents and the skin percents of these 
membranes. 
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Figure 7.21. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Octanol. Magnificationx10000. 
 
Figure 7.22. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Octanol. Magnificationx20000. 
The membrane prepared using 1-octanol as nonsolvent has small pores having average 
pore size of 0.5 µm. The pores have uniform cylindrical shapes, which can be easily 
observed in Figure 7.22 with the magnification of 20000. This membrane has the 
highest release rate since it has the smallest percentage of skin layer among the other 
membranes. 
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Figure 7.23. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Formamide. Magnificationx5000. 
Membrane prepared from formamide were transparent indicated that no phase 
separation occurred. The resulting structure is dense and shown in Figure 7.23.  
 
Figure 7.24. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Glycerol. Magnificationx1250. 
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Macrovoids were observed in membrane prepared from glycerol as shown in Figure 
7.24. Due to the presence of macrovoids, the overall thickness of the membrane is 
highest among the others. 
 
Figure 7.25. SEM picture of cross section of a membrane. Initial composition: 
10% CA, 80% Acetone, 10% Hexanol. Magnificationx5000. 
 
Figure 7.26. SEM picture of the top layer of membrane. Initial composition: 
10% CA, 80% Acetone, 10% Hexanol. Magnificationx20000. 
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Figure 7.27. SEM picture of the mid section of membrane. Initial composition: 
10% CA, 80% Acetone, 10% Hexanol. Magnificationx10000. 
The membrane prepared from 1-hexanol has uniform cylindrical pores with the average 
size of 1.24 µm and 13.4% skin layer that is the maximum value compared to the other 
membranes. Figure 7.25 through 7.27 show SEM pictures of the cross section, top and 
the mid of the cross section of this membrane. At the top of the membrane, there is 
sponge like structure and pores are interconnected to each other while in the middle 
section macropores were observed, thus, the membrane has a large pore size 
distribution.  
The change in % of skin layer with the nonsolvent type is also plotted in Figure 7.20. 
According to this figure, the decrease in release rate is associated with the increase in 
the resistance of the skin layer.  
Diversity in the morphologies of the membranes prepared from different nonsolvents is 
due to complex mechanism of membrane formation. The membrane formation process 
and subsequent structure is not only influenced by initial composition and preparation 
conditions but it is also affected by the thermodynamic behavior and the diffusional 
characteristics of the components in the membrane solution. 
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7.2. Permeability Studies 
Membranes cast from solutions of cellulose acetate (CA), acetone (Ac), water (W) were 
used to investigate the permeability characteristics. Initial casting thickness of the 
membranes was 300 µm. Six different types of asymmetric membranes were prepared 
by varying the composition. To illustrate the advantage of the asymmetric membranes, 
permeability of dense membrane prepared from the solution of cellulose acetate 
dissolved in acetone was also measured. 
Permeabilities were determined using the diaphragm cell model discussed in Chapter 4 
in section 4.3. For this purpose, equations 4.17 and 4.18 were applied to fit the 
experimental data consisting of the concentrations in the donor and receiver 
compartments at different times. In these equations, the permeability, Peff , was used as 
a fitting parameter. The nonlinear curve fitting was performed using solver tool in Excel 
by minimizing the sum of the squared errors: 
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Table 7.4. lists the values of permeabilities determined from the nonlinear regression 
analysis. 
Table 7.4. Permeability and thickness of the membranes. 
Composition 
 
CA Ac W 
Permeability 
(cm2/min) 
Total Thickness 
(µm) 
Skin Thickness 
(µm) 
10 90 0 7.1316 x 10-7 8.40 - 
10 80 10 5.3190 x 10-6 16.05 1.14 
5 80 15 5.7208 x 10-6 10.52 0.63 
15 80 5 2.1149 x 10-6 15.27 5 
5 85 10 1.5913 x 10-5 26.09 - 
15 75 10 7.0210 x 10-6 20.06 1.85 
15 70 15 1.2201 x 10-5 34.91 2.58 
Figure 7.28 shows the variation of reduced permeability with the percentage of the skin 
layer. 
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Figure 7.28. Relationship between the percentage of skin layer and Peff / Pdense ratio.  
Reduced permeabilities were calculated by dividing the permeability of asymmetric 
membrane to that of the dense membrane. According to the results shown in Figure 
7.28, normalized permeability of the asymmetric membranes decreases exponentially 
with the increase in the percentage of the skin layer. Thus, the increase in thickness of 
the skin layer leads to the increase in overall resistance to transport of drug molecules 
and consequently the decrease in permeabilities.  
The results shown in Figure 7.28 point out that the permeability of the asymmetric type 
coating can be adjusted by controlling the membrane structure. Thus, release kinetics of 
drug can be controlled without changing the coating material or significantly varying 
the overall coating thickness. 
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7.3. Statistical Analysis of Experiments 
7.3.1. Determination of the Variables and Feasible Region for the Design of 
Experiments 
As a first step in designing the experiments, the variables influencing the response 
chosen as the release rate of the theophylline were determined. These are initial 
composition of the coating solution, type of nonsolvent, number of coatings, coating 
time and evaporation condition. Based on the preliminary results of the experiments and 
the literature data, it was concluded that the most influential parameter on the 
membrane structure and thus on the release rate is the initial composition of the coating 
solution. Consequently, the experiments were designed to find relationship of 
The release rate = f (x1, x2, x3) 
in which x1, x2, x3 are the compositions of the cellulose acetate, acetone and water in 
weight percentages, respectively. The second step in the design of experiments was to 
determine the range of variables, i.e, the design region. The composition of each 
component has both upper and lower bound constraints which were determined based 
on the simulation results of Özbaş (2001) and the available literature data. These 
constraints are: 
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Figure 7.29 shows the feasible region for the design of experiments in a ternary 
diagram. 
7.3.2. Mixture Design 
The experimental region shown in Figure 7.29 is not a standard shape, i.e., the feasible 
region is not a simplex. Therefore, the D-optimal design was generated using 
commercial software called Design-Expert. The results of the design are listed in Table 
7.5 and the constrained experimental region with the experimental run points is shown 
in Figure 7.30.  
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Figure 7.29. The feasible region for the design of experiments 
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Table 7.5. D-optimal design for the mixture of membrane solution. 
Standard 
Order 
A: Cellulose 
Acetate B: Acetone C: Water 
1 15 80 5 
2 15 80 5 
3 5 90 5 
4 5 90 5 
5 15 70 15 
6 15 70 15 
7 5 80 15 
8 5 80 15 
9 5 85 10 
10 10 80 10 
11 15 75 10 
12 10 85 5 
13 77.5 12.5 10 
14 10 75 15 
 
 
Figure 7.30. The constrained experimental region the design of experiments. 
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In the 14-run design, six experimental runs are required to fit the quadratic mixture 
model, four additional distinct runs are required to check for the lack of fit and finally 
four runs are replicated to provide an estimate of pure error. According to the results 
shown in Table 7.5, Design-Expert used the vertices, the edge centers, the overall 
centroid and one point located halfway between the overall centroid and one of the edge 
centers as candidate points. Additionally, four vertices of the design region were used 
again as check points. 
7.3.3. The Regression Model and Statistical Analysis 
The statistical analysis of the experimental results was performed using Design-Expert 
software package. The output from this program is shown in Appendix C. The data was 
best fitted to the special cubic equation. The resulting equation for predicting the release 
rate of theophylline is given as follows: 
The Release Rate = 40.38107 x1 + 1.27250 x2 + 26.64414 x3 – 56.47210 x1 x2 
-260.60344 x1 x3 – 37.10052 x2 x3 + 301.559710 x1 x2 x3    (7.5) 
The statistical analyses of the experimental release rate data are given in Tables 7.6 and 
7.7. In Table 7.6, an analysis of variance (ANOVA) for the model given in equation 7.5 
is presented. The first line of the analysis of variance is an overall summary for the full 
model. The symbols A, B, C refer to cellulose acetate, acetone and water, respectively. 
The sum of squares is used as a measure of overall variability in the data. The    
 value of 0.17 indicates that variation in the experimental data is very small. Mean 
square values are obtained by dividing the sum of squares by the degrees of freedom. 
The model F-value of 39.97 implies that the model is significant. There is only a 0.01% 
chance that a “Model F-value” this large occurs due to noise. The importance of each 
term, i.e., the influence of cross interaction between/among the components on the 
release rate is shown by the values in column “Prob>F”. Values of “Prob>F” less than 
0.05 indicate that model terms are significant. In this case, the interaction between 
cellulose acetate (A) and acetone (B) has the largest influence on the release rate of 
theophylline since the value of Prob>F is the smallest for the model term AB. The 
interaction between acetone and water has the least influence on the release rate of 
theophylline. Values of “Prob>F” greater than 0.1 indicate that the model terms are not 
significant. 
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Table 7.6. Analysis of Variance (ANOVA) for the release rate data. 
Source Sum of Squares DF 
Mean 
Square F Value Prob>F 
 
Model 0.17 6 0.028 39.97 <0.0001 significant 
Linear Mixture 0.14 2 0.069 98.25 <0.0001  
AB 0.014 1 0.014 20.29 0.0028  
AC 7.212E-3 1 7.212E-3 10.30 0.0149  
BC 4.123E-3 1 4.123E-3 5.89 0.0457  
ABC 4.779E-3 1 4.779E-3 6.82 0.0348  
Residual 4.902E-3 7 7.003E-4    
Lack of Fit 8.518E-4 3 2.839E-4 0.28 0.8378 not significant 
Pure Error 4.050E-3 4 1.013E-3    
Cor Total 0.17 13     
Table 7.7. Statistical analysis of the release rate data. 
Std. Dev. 0.026 
Mean 0.099 
C.V 26.82 
PRESS 0.020 
R2 0.9716 
Adj. R2 0.9473 
Pred. R2 0.8851 
Adeq. Precision 16.631 
Table 7.7 lists the results of several R2 statistics. Simply, the ordinary R2 measures the 
proportion of total variability explained by the analysis of variance model. The large 
value of R2, close to 1 is desirable. There are some other R2 statistics displayed in the 
table. The adjusted R2 reflects the number of factors in the model. “Std.Dev.” is the 
square root of the error mean square. “C.V.” is the coefficient of variation which 
measures the unexplained or residual variability in the data. “PRESS” stands for 
“Prediction Error Sum of Squares” and it is a measure of how well the regression model 
is likely to predict the response in a new experiment. Small values of PRESS are 
desirable, since it indicates that the model is likely to be a good predictor. The 
“Adequate Precision” is computed by dividing the difference between the maximum 
and minimum predicted release rates by the average standard deviation of all predicted 
release rates. Large values of this quantity are desirable, the value of 16.6 in Table 7.7 
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points out that the model given in equation 7.5 will give reasonable performance in 
prediction. The “Lack of Fit F-Value” of 0.28 implies the Lack of Fit is not significant 
relative to the pure error. Non-significant lack of fit is an indication of the accuracy of 
the model used to fit the experimental data. 
7.3.4. The Response Surface Plot 
Figure 7.31 presents contour plots of the surface generated by the model equation 
shown in equation 7.5. 
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Figure 7.31. Contour plots in the D-optimal design area. 
The feasible region is shown by the unshaded region. The circles represent the design 
points while number 2 at corners indicates the repeated experimental points. Contour 
plots are useful since they can provide compositions that can be chosen for a given 
release rate of theophylline. The three dimensional surface plots shown in Figure 7.32 
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provide essentially the same information. These three successive plots show the 
response surfaces from different perspectives. The results shown in Figure 7.32 indicate 
that within the experimental region, the maximum release rate of theophylline is 0.312 
mg/min which is obtained when the compositions of cellulose acetate, acetone and 
water are 5%, 90% and 5% respectively. 
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Figure.7.32. Three dimensional surface plot for design area. 
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CONCLUSION 
In this study, asymmetric type of coatings have been applied to tablets. The advantages 
of these type of coatings over the conventional dense coatings were demonstrated both 
by dissolution and permeability studies. The advantages are acquired due to flexibility 
in changing the structure of the coating by varying the preparation conditions. In 
particular, the effects of composition of the membrane solution, the type of nonsolvent, 
coating time, number of coating layers and evaporation conditions on the release rate 
and the structure of the membrane were examined. In these experiments, one factor-at-a 
time approach was followed in which only factor being investigated was varied while 
all other factors were held constant at the baseline set of levels. The baseline levels of 
variables were chosen as follows: Initial composition: 10 w% polymer (cellulose 
acetate), 80 w% solvent (acetone) and 10 w% nonsolvent (water), coating time: 1 min, 
number of coating layer: 1, evaporation condition: free convection. According to this 
baseline scheme, the increase in coating time and the number of coating layers 
decreased the release rate of theophylline. The decrease in each case is due to the 
increase in transport resistance to drug molecules associated with an increase in length 
of the diffusion path. Evaporation condition was found to have a significant influence 
on the structure and thus the release rate of the drug. The change in evaporation 
condition during drying of coated tablets from free convection to forced convection 
caused a substantial decrease in release rate of drug. The scanning electron microscope 
pictures of both membranes indicated that the structure changed from asymmetric 
porous type to a dense one as air was blown harder to dry tablets. In addition to water, 
octanol, hexanol, glycerol and formamide were used as nonsolvents in the coating 
solution. The highest release rate was obtained with octanol, while, the coating prepared 
from hexanol gave the lowest  release rate of drug. The comparison of scanning electron 
microscope pictures of the membranes pointed out that the decrease in release rate of 
the membranes prepared from different nonsolvents was due to the increase in the 
thickness of the dense skin layer, thus, the increase in resistance of this layer. Statistical 
design of experiments was performed to draw more meaningful and objective 
conclusions from the data. In the design of experiments, the compositions of cellulose 
acetate, acetone and water were chosen as the parameters influencing the release rate of 
the drug. The results of the statistically designed experiments have shown that the 
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increase in P/NS ratio caused an exponential decrease in release rate. From the detailed 
phase analysis and structure of the membranes, it was seen that the increase in P/NS 
ratio leads to a decrease in porosity of the membranes, while the fraction of dense skin 
layer increased. Thus both the resistance of the skin layer as well as the resistance of the 
substrate increased. However, the contribution of substrate resistance on the overall 
resistance was found to be more dominant with increasing P/NS ratio. The same trend 
was observed with increasing P/S ratio. In particular, the effect of substrate resistance 
becomes more important as P/S ratio increases leading to increase in overall resistance 
to transport of drug, and thus, substantial decrease in release rate. At higher polymer 
concentrations, a maximum in release rate was observed as S/NS ratio was increased. At 
low S/NS ratios, the resistance of skin layer becomes more important while at high 
S/NS ratios, the contribution of the substrate resistance is larger. The results of 
statistically designed experiments indicated that the release rate of theophylline can be 
considerably changed by varying P/S, P/NS or S/NS ratios without changing the coating 
material or solvent, nonsolvent type. In addition, the statistical analysis of the 
experimental data and the regression model pointed out that the interactions between 
cellulose acetate/acetone have the most prominent effect on the release rate of 
theophylline. However, the interactions between cellulose acetate/water and 
acetone/water also influence the release rate of theophylline. Permeability studies also 
indicated that the permeability of the coating to drug molecules can be adjusted by 
varying the composition of the membrane solution. The advantage of the asymmetric 
type coating on tablets is not only adjusting the release rate of drug by varying the 
preparation conditions. All of the results from dissolution studies indicated the 
fulfillment of the zero-order release requirement for controlled-release systems. It can 
be finally concluded that asymmetric membrane tablet coatings could provide improved 
drug delivery formulations capable of releasing the drug at constant and desired rates. 
Future work should involve the investigation of solvent type, combination of solvents 
and nonsolvents in the coating solution as well as the composite coatings prepared from 
different polymers. 
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APPENDIX A 
 
Figure A.1. UV spectrum of theophylline anhydrate in water. 
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APPENDIX B 
Preparation of Solutions For Calibration Curve 
0.05 g of theophylline anhydrate was dissolved in 25 ml bidistilled water. From this solution, 
25, 37.5, 50, 75, 100, 125, 150, 175, 200 µL of samples were taken and diluted with 
bidistilled water to 25 ml. Same procedures were applied to prepare phospate buffer solutions 
with pH 3 and pH 7.4, respectively. 
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Figure B.1. Calibration curve of theophylline in water solution. 
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Figure B.2. Calibration curve of theophylline in pH 3 phosphate buffer solution. 
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Figure B.3. Calibration curve of theophylline in pH 7.4 phosphate buffer solution. 
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APPENDIX C 
Output of DESIGN-EXPERT 
Response: release rate 
ANOVA for Mixture Special Cubic Model 
Analysis of variance table [Partial sum of squares] 
 Sum of  Mean F   
Source Squares DF Square Value Prob > F  
Model 0.17 6 0.028 39.97 < 0.0001 significant 
Linear Mixture 0.14 2 0.069 98.25 < 0.0001  
AB 0.014 1 0.014 20.29 0.0028  
AC 7.212E-003 1 7.212E-003 10.30 0.0149  
BC 4.123E-003 1 4.123E-003 5.89 0.0457  
ABC 4.779E-003 1 4.779E-003 6.82 0.0348  
Residual 4.902E-003 7 7.003E-004    
Lack of Fit 8.518E-004 3 2.839E-004 0.28 0.8378 not significant 
Pure Error 4.050E-003 4 1.013E-003    
Cor Total 0.17 13     
 
The Model F-value of 39.97 implies the model is significant. There is only a 0.01% 
chance that a "Model F-Value" this large could occur due to noise. 
Values of "Prob > F" less than 0.0500 indicate model terms are significant. 
In this case Linear Mixture Components, AB, AC, BC, ABC are significant model 
terms. 
Values greater than 0.1000 indicate the model terms are not significant. 
If there are many insignificant model terms (not counting those required to support 
hierarchy), model reduction may improve your model. 
The "Lack of Fit F-value" of 0.28 implies the Lack of Fit is not significant relative to 
the pure error.There is a 83.78% chance that a "Lack of Fit F-value" this large could 
occur due  
to noise. Non-significant lack of fit is good -- we want the model to fit. 
  
C2 
 Std. Dev. 0.026  R-Squared 0.9716 
 Mean 0.099  Adj R-Squared 0.9473 
 C.V. 26.82  Pred R-Squared 0.8851 
 PRESS 0.020  Adeq Precision 16.631 
 
The "Pred R-Squared" of 0.8851 is in reasonable agreement with the "Adj R-Squared" 
of 0.9473.  
"Adeq Precision" measures the signal to noise ratio.  A ratio greater than 4 is desirable. 
Your ratio of 16.631 indicates an adequate signal.  This model can be used to navigate 
the design space. 
 Coefficient  Standard 95% CI 95% CI 
Component Estimate DF Error Low High 
A-CA 0.52 1 0.19 0.076 0.96 
B-Ac 0.31 1 0.019 0.27 0.36 
C-W 0.48 1 0.18 0.047 0.92 
AB -1.66 1 0.37 -2.52 -0.79 
AC -1.98 1 0.62 -3.44 -0.52 
BC -0.88 1 0.36 -1.74 -0.022 
ABC 2.41 1 0.92 0.23 4.60 
 Final Equation in Terms of Pseudo Components: 
   release rate  = 
  +0.52   * A 
  +0.31   * B 
  +0.48   * C 
  -1.66   * A * B 
  -1.98   * A * C 
  -0.88   * B * C 
  +2.41  * A * B * C 
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  Final Equation in Terms of Real Components: 
   release rate  = 
  +40.38107   * CA 
  +1.27250   * Ac 
  +26.64414   * W 
  -56.47210   * CA * Ac 
  -260.60344   * CA * W 
  -37.10052   * Ac * W 
  +301.55970  * CA * Ac * W 
 
  Final Equation in Terms of Actual Components: 
   release rate  = 
  +40.38107   * CA 
  +1.27250   * Ac 
  +26.64414   * W 
  -56.47210   * CA * Ac 
  -260.60344   * CA * W 
  -37.10052   * Ac * W 
  +301.55970  * CA * Ac * W 
 
Diagnostics Case Statistics 
 
Standard Actual Predicted   Student Cook's Outlier 
Order Value Value Residual Leverage Residual Distance t 
1 0.18 0.19 -0.010 0.674 -0.669 0.132 -0.640 
2 0.18 0.18 2.437E-003 0.438 0.123 0.002 0.114 
3 0.054 0.063 -9.384E-003 0.647 -0.597 0.093 -0.567 
4 7.200E-003 5.396E-003 1.804E-003 0.492 0.096 0.001 0.089 
5 3.600E-003 1.529E-003 2.071E-003 0.442 0.105 0.001 0.097 
6 0.36 0.31 0.047 0.492 2.506 0.869 7.226 * 
7 3.600E-003 1.529E-003 2.071E-003 0.442 0.105 0.001 0.097 
8 9.000E-003 0.015 -5.950E-003 0.326 -0.274 0.005 -0.255 
9 0.18 0.18 2.437E-003 0.438 0.123 0.002 0.114 
10 8.100E-003 5.396E-003 2.704E-003 0.492 0.143 0.003 0.133 
11 0.27 0.31 -0.043 0.492 -2.267 0.711 -4.068 * 
12 0.045 0.054 -8.652E-003 0.682 -0.580 0.103 -0.550 
13 0.018 0.024 -5.796E-003 0.534 -0.321 0.017 -0.299 
14 0.063 0.041 0.022 0.408 1.073 0.114 1.087 
  * Case(s) with |Outlier T| > 3.50 
 
  
C4 
Proceed to Diagnostic Plots (the next icon in progression).  Be sure to look at the: 
1) Normal probability plot of the studentized residuals to check for normality of 
residuals. 
2) Studentized residuals versus predicted values to check for constant error. 
3) Outlier t versus run order to look for outliers, i.e., influential values. 
4) Box-Cox plot for power transformations. 
 
